All In Biotech

Free tool

FAERS Monitor: Recorlev

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214133 or its brand name (Recorlev, Levoketoconazole). Reports on generic versions are filed under their own applications.

Reports

756

Serious

438

58% of reports

Hospitalization

195

Death reported

14

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue256
  • nausea222
  • headache181
  • dizziness117
  • vomiting105
  • diarrhoea94
  • pain87
  • weight decreased84
  • malaise79
  • insomnia77
  • arthralgia73
  • asthenia73
  • decreased appetite67
  • feeling abnormal66
  • abdominal discomfort59

Reports by year received

View as table
YearReports
202249
202388
202492
2025145
2026382

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,403 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
abdominal discomfortSignal599.87.7460
fatigueSignal2569.28.31,921
weight decreasedSignal848.46.8545
insomniaSignal778.06.5474
headacheSignal1818.07.11,141
decreased appetiteSignal678.06.4410
nauseaSignal2227.87.01,361
feeling abnormalSignal667.76.1380
dizzinessSignal1176.55.5555
vomitingSignal1056.25.2464
astheniaSignal735.44.3262
malaiseSignal795.04.1255
arthralgiaSignal734.93.9226
diarrhoeaSignal944.13.4220
painSignal873.93.2194

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.